Novavax (NVAX) Reports Q3 Loss, Beats Revenue Estimates

Novavax (NVAX) came out with a quarterly loss of $0.62 per share versus the Zacks Consensus Estimate of a loss of $1.08. This compares to a loss of $0.76 per share a year ago. These figures are adjusted for non-recurring items.This quarterly report represents an earnings surprise of +42.59%. A quarter ago, it was expected that this vaccine maker would post a loss of $0.07 per share when it actually produced earnings of $0.62, delivering a surprise of +985.71%.Over the last four quarters, the company has sur ...